PDCD1 and neoplasm: Nanogels can locally deliver agents that counteract immunosuppression (TGF-β inhibitors and IL-2) to restore T-cell function [15], while nano-scaffolds displaying anti-PD-1/anti-PD-L1 can physically couple T cells to tumor cells to promote antigen-specific cytotoxicity [16].